Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Rx Seen As Helpful By 33% Of Low-Income Seniors – Kaiser Survey

This article was originally published in The Pink Sheet Daily

Executive Summary

Results of a Kaiser Family Foundation/Harvard School of Public Health survey also show about a third of the overall Medicare population believes the drug benefit will help them personally. Almost half of respondents had an unfavorable view of the law.

You may also be interested in...



Drug Discount Cards Considered "Not Worth The Trouble" By Most Seniors, Kaiser Says

The majority of Medicare beneficiaries say the program's approved drug discount cards "aren't worth the trouble" of enrolling, according to Kaiser Family Foundation/Harvard School of Public Health survey results released Aug. 10

Drug Discount Cards Considered "Not Worth The Trouble" By Most Seniors, Kaiser Says

The majority of Medicare beneficiaries say the program's approved drug discount cards "aren't worth the trouble" of enrolling, according to Kaiser Family Foundation/Harvard School of Public Health survey results released Aug. 10

Seniors Will Save 53% On Drug Spending Under Medicare Rx, CMS Says

Medicare beneficiaries will save an average of 53% on out-of-pocket drug costs under the standard Part D prescription drug benefit, the Centers for Medicare & Medicaid Services projects

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS060256

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel